Aegerion Pharmaceuticals, Inc. Announces Participation at Wells Fargo Securities 2012 Healthcare Conference

CAMBRIDGE, Mass., June 13, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Wells Fargo Securities 2012 Healthcare Conference in Boston. Marc D. Beer, CEO of Aegerion, is scheduled to present on Wednesday, June 20, 2012 at 2:10 p.m. ET.
MORE ON THIS TOPIC